Raymond James & Associates’s Achillion Pharmaceuticals, Inc. ACHN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q1
Sell
-27,216
Closed -$164K 3700
2019
Q4
$164K Sell
27,216
-54,884
-67% -$331K ﹤0.01% 3368
2019
Q3
$296K Buy
82,100
+13,685
+20% +$49.3K ﹤0.01% 2998
2019
Q2
$183K Sell
68,415
-7,000
-9% -$18.7K ﹤0.01% 3268
2019
Q1
$223K Buy
75,415
+3,965
+6% +$11.7K ﹤0.01% 3154
2018
Q4
$114K Buy
71,450
+7,400
+12% +$11.8K ﹤0.01% 3263
2018
Q3
$236K Buy
64,050
+1,000
+2% +$3.69K ﹤0.01% 3172
2018
Q2
$178K Buy
63,050
+200
+0.3% +$565 ﹤0.01% 3272
2018
Q1
$233K Sell
62,850
-5,600
-8% -$20.8K ﹤0.01% 3039
2017
Q4
$197K Sell
68,450
-19,000
-22% -$54.7K ﹤0.01% 3043
2017
Q3
$393K Sell
87,450
-12,115
-12% -$54.4K ﹤0.01% 2613
2017
Q2
$457K Buy
99,565
+2,100
+2% +$9.64K ﹤0.01% 2469
2017
Q1
$410K Sell
97,465
-5,500
-5% -$23.1K ﹤0.01% 2504
2016
Q4
$425K Sell
102,965
-9,000
-8% -$37.1K ﹤0.01% 2419
2016
Q3
$907K Buy
111,965
+7,784
+7% +$63.1K ﹤0.01% 1946
2016
Q2
$813K Buy
104,181
+5,181
+5% +$40.4K ﹤0.01% 1849
2016
Q1
$764K Sell
99,000
-19,702
-17% -$152K ﹤0.01% 1810
2015
Q4
$1.28M Buy
118,702
+6,552
+6% +$70.7K ﹤0.01% 1501
2015
Q3
$775K Sell
112,150
-8,073
-7% -$55.8K ﹤0.01% 1726
2015
Q2
$1.07M Sell
120,223
-2,477
-2% -$21.9K ﹤0.01% 1699
2015
Q1
$1.21M Buy
122,700
+28,793
+31% +$284K 0.01% 1550
2014
Q4
$1.15M Buy
93,907
+42,207
+82% +$517K 0.01% 1486
2014
Q3
$516K Sell
51,700
-18,700
-27% -$187K ﹤0.01% 1839
2014
Q2
$533K Sell
70,400
-75,600
-52% -$572K ﹤0.01% 1810
2014
Q1
$480K Buy
+146,000
New +$480K ﹤0.01% 1803